UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2006
OR
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
For the transition period from.............to.....................
Commission file number 1-225
KIMBERLY-CLARK CORPORATION
(Exact name of registrant as specified in its charter)
Delaware
39-0394230
(State or other jurisdiction of
(I.R.S. Employer
incorporation or organization)
Identification No.)
P. O. Box 619100
Dallas, Texas
75261-9100
(Address of principal executive offices)
(Zip Code)
(972) 281-1200
(Registrants telephone number, including area code)
No change
(Former name, former address and former fiscal year, if changed since last report)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes X .
No
___.
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of accelerated filer and large accelerated filer in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer X .
Accelerated filer
Non-accelerated filer ___.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes
No X .
As of October 31, 2006, there were 458,305,998 shares of the Corporations common stock outstanding.
PART I FINANCIAL INFORMATION
Item 1. Financial Statements.
KIMBERLY-CLARK CORPORATION AND SUBSIDIARIES
CONSOLIDATED INCOME STATEMENT
(Unaudited)
Three Months Ended
Nine Months Ended
September 30
(Millions of dollars, except per share amounts)
2006
2005
Net Sales
$
4,210.4
4,000.8
12,439.7
11,893.7
Cost of products sold
2,934.9
2,844.4
8,723.5
8,108.1
Gross Profit
1,275.5
1,156.4
3,716.2
3,785.6
Marketing, research and general expenses
749.2
679.5
2,203.6
2,021.5
Other (income) and expense, net
(.1
)
12.3
21.7
25.7
Operating Profit
526.4
464.6
1,490.9
1,738.4
Nonoperating expense
(17.2
(43.2
(40.6
(137.4
Interest income
6.8
7.4
19.8
Interest expense
(56.5
(48.0
(165.9
(138.2
Income Before Income Taxes and
Equity Interests
459.5
380.8
1,304.2
1,484.5
Provision for income taxes
(114.6
(66.3
(344.9
(324.3
Income Before Equity Interests
344.9
314.5
959.3
1,160.2
Share of net income of equity companies
42.8
33.0
124.7
99.4
Minority owners share of subsidiaries net
income
(23.5
(22.2
(67.1
(62.4
Net Income
364.2
325.3
1,016.9
1,197.2
Per Share Basis:
Basic
.80
.69
2.22
2.51
Diluted
.79
.68
2.21
2.49
Cash Dividends Declared
.49
.45
1.47
1.35
See Notes to Consolidated Financial Statements.
2
CONDENSED CONSOLIDATED BALANCE SHEET
September 30,
December 31,
(Millions of dollars)
ASSETS
Current Assets
Cash and cash equivalents
399.2
364.0
Accounts receivable
2,192.6
2,101.9
Inventories
1,888.3
1,752.1
Other current assets
560.7
565.1
Total Current Assets
5,040.8
4,783.1
Property
15,044.6
14,616.2
Less accumulated depreciation
7,563.6
7,121.5
Net Property
7,481.0
7,494.7
Investments in Equity Companies
494.2
457.8
Goodwill
2,731.9
2,685.6
Other Assets
877.9
882.0
16,625.8
16,303.2
LIABILITIES AND STOCKHOLDERS EQUITY
Current Liabilities
Debt payable within one year
1,360.6
1,222.5
Accounts payable
1,400.5
1,354.3
Accrued expenses
1,530.1
1,399.6
Other current liabilities
592.0
666.5
Total Current Liabilities
4,883.2
4,642.9
Long-Term Debt
2,272.1
2,594.7
Noncurrent Employee Benefit and Other Obligations
1,891.8
1,782.6
Deferred Income Taxes
407.9
572.9
Minority Owners Interests in Subsidiaries
419.6
394.5
Preferred Securities of Subsidiary
784.2
757.4
Stockholders Equity
5,967.0
5,558.2
3
CONDENSED CONSOLIDATED CASH FLOW STATEMENT
Nine Months
Ended September 30
Operating Activities
Net income
Depreciation and amortization
714.5
624.6
Asset impairments
3.4
67.0
Stock-based compensation
53.0
24.8
Changes in operating working capital
54.6
(254.5
Deferred income tax provision
(217.8
(76.3
Net losses on asset dispositions
81.4
27.7
Equity companies earnings in excess of dividends paid
(62.0
(40.9
Minority owners share of subsidiaries net income
67.1
62.4
Postretirement benefits
62.8
47.4
Other
(7.4
(43.7
Cash Provided by Operations
1,766.5
1,635.7
Investing Activities
Capital spending
(639.0
(451.9
Proceeds from sales of investments
29.4
20.9
Proceeds from dispositions of property
32.3
Net (increase) decrease in time deposits
(16.0
44.1
Investments in marketable securities
(18.7
(2.0
(5.1
(21.4
Cash Used for Investing
(617.1
(382.6
Financing Activities
Cash dividends paid
(659.6
(625.7
Net (decrease) increase in short-term debt
(147.6
212.1
Proceeds from issuance of long-term debt
52.8
359.9
Repayments of long-term debt
(95.9
(550.5
Proceeds from exercise of stock options
220.0
131.4
Acquisitions of common stock for the treasury
(479.4
(1,013.6
(3.5
(32.3
Cash Used for Financing
(1,113.2
(1,518.7
Effect of Exchange Rate Changes on Cash and Cash Equivalents
(1.0
(15.0
Increase (Decrease) in Cash and Cash Equivalents
35.2
(280.6
Cash and Cash Equivalents, beginning of year
594.0
Cash and Cash Equivalents, end of period
313.4
4
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note 1. Accounting Policies
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the U.S. for complete financial statements. In the opinion of management, all adjustments, consisting of normal recurring adjustments, considered necessary for a fair presentation have been included.
For further information, refer to the consolidated financial statements and footnotes thereto included in the Corporations Annual Report on Form 10-K for the year ended December 31, 2005.
New Accounting Standards
In June 2006, the Financial Accounting Standards Board (FASB) issued Interpretation No. 48, Accounting for Uncertainty in Income Taxes, an interpretation of FASB Statement 109 (FIN 48). FIN 48 clarifies the accounting for uncertainty in income taxes recognized in the financial statements by standardizing the level of confidence needed to recognize uncertain tax benefits and the process for measuring the amount of benefit to recognize. FIN 48 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. FIN 48 is effective for fiscal years beginning after December 15, 2006. The Corporation will adopt FIN 48 as of January 1, 2007, as required. The cumulative effect of adopting FIN 48 will be recorded in retained earnings. The Corporation is currently evaluating the interpretation. However, adoption of FIN 48 is not expected to have a material effect on the Corporations financial statements.
In September 2006, the FASB issued Statement of Financial Accounting Standards (SFAS) No. 157, Fair Value Measurements (SFAS 157). SFAS 157 defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. SFAS 157 does not require any new fair value measurements; however, it will apply under other accounting pronouncements that require or permit fair value measurements. SFAS 157 is effective for fiscal years beginning after December 15, 2007 and interim periods within such years. The Corporation will adopt SFAS 157 as of January 1, 2008, as required. The Corporation is currently evaluating the new standard. However, adoption of SFAS 157 is not expected to have a material effect on the Corporations financial statements.
In September 2006, the FASB issued SFAS No. 158, Employers Accounting for Defined Benefit Pension and Other Postretirement Plans, an amendment of FASB Statements Nos. 87, 88, 106 and 132R (SFAS 158). SFAS 158 requires an employer that sponsors one or more postretirement defined benefit plan(s) to:
Recognize the funded status of postretirement defined benefit plans measured as the difference between the fair value of plan assets and the benefit obligations in its consolidated balance sheet.
Recognize changes in the funded status of postretirement defined benefit plans in other comprehensive income in the year in which the changes occur.
5
Note 1. (Continued)
Measure postretirement defined benefit plan assets and obligations as of the date of the employers fiscal year-end. The Corporation presently uses December 31 as the measurement date for all of its postretirement defined benefit plans.
The Corporation will adopt SFAS 158 effective December 31, 2006, as required. Adoption of SFAS 158 is estimated to increase the Corporations liabilities, net of deferred income tax effects, by more than $350 million and decrease stockholders equity by a similar amount. Adoption of SFAS 158 is not expected to have a significant effect on the Corporations results of operations or liquidity.
In September 2006, the Securities and Exchange Commission published Staff Accounting Bulletin No. 108 (SAB 108), which expresses the Staffs views regarding the process of quantifying financial statement misstatements. SAB 108 describes the two techniques most commonly used in practice to quantify misstatements as the rollover and iron curtain approaches.
The rollover approach quantifies a misstatement based on the amount of the misstatement originating in the current year income statement, thereby ignoring the carryover effects of prior year misstatements. The iron curtain approach quantifies a misstatement based on the effects of correcting the misstatement existing in the balance sheet at the end of the current year, irrespective of the misstatements year(s) of origination.
SAB 108 requires quantification of all misstatements on both the rollover and iron curtain approaches, and if either approach results in a material effect on the financial statements, the financial statements should be adjusted. The Corporation will adopt SAB 108 by December 31, 2006, as required. The Corporation is currently evaluating the effect that application of SAB 108 will have, but adoption is not expected to have a material effect on the Corporations financial statements.
Note 2. Stock-Based Compensation
The Corporation has a stock-based Equity Participation Plan and an Outside Directors Compensation Plan (the Plans), under which it currently grants options, restricted shares and restricted share units to employees and restricted share units to outside directors. As of September 30, 2006, the number of shares of common stock available for grants under the Plans aggregated 24.9 million shares.
Stock options are granted at an exercise price equal to the market value of the underlying common stock on the date of grant. The Corporations stock options have a term of 10 years and are subject to graded vesting whereby options vest 30 percent at the end of each of the first two 12 month periods following the grant and 40 percent at the end of the third 12 month period.
Restricted shares, time-based restricted share units and performance-based restricted share units granted to employees generally vest over three to five years. The number of performance-based share units that ultimately vest ranges from zero to 150 percent of the number granted, based on improvement in return on invested capital (ROIC) during the three-year performance period. ROIC targets are set at the beginning of the performance period. Restricted share units granted to outside directors generally vest upon their departure from the board of directors.
At the time stock options are exercised or restricted shares and restricted share units vest, common stock is issued from the Corporations accumulated treasury shares. Cash dividends are paid on restricted shares, and cash dividends or dividend equivalents are paid or credited on restricted share units, on the same date and at the same rate as dividends are paid on the Corporations common stock. These cash dividends and dividend equivalents, net of estimated forfeitures, are charged to retained earnings. Previously paid cash dividends on subsequently forfeited restricted share units are charged to compensation expense.
6
Note 2. (Continued)
Prior to January 1, 2006, the Corporation accounted for these plans under the recognition and measurement provisions of Accounting Principles Board (APB) No. 25, Accounting for Stock Issued to Employees (APB 25), and related interpretations, as permitted by SFAS No. 123, Accounting for Stock-Based Compensation (SFAS 123). No employee compensation cost for stock options was recognized in the Consolidated Income Statement for periods prior to January 1, 2006, as all stock options granted had an exercise price equal to the market value of the underlying common stock on the date of grant.
Effective January 1, 2006, the Corporation adopted the fair value recognition provisions of SFAS No. 123R, Share-Based Payment (SFAS 123R), using the modified-prospective-transition method. Under that transition method, compensation cost is recognized in the periods after adoption for (i) all stock option awards granted or modified after December 31, 2005 based on the grant-date fair value estimated in accordance with the provisions of SFAS 123R and (ii) all stock options granted prior to but not yet vested as of January 1, 2006, based on the grant date fair value estimated in accordance with the original provisions of SFAS 123. Results for prior periods were not restated. Also in connection with the adoption of SFAS 123R, approximately $37 million was reclassified from accrued liabilities to additional paid-in capital, as accrued compensation for unvested restricted share units does not meet the definition of a liability under SFAS 123R.
Stock-based employee compensation cost of $16.9 million and $53.0 million were recognized for the three and nine months ended September 30, 2006, respectively. Related income tax benefits of $6.3 million and $18.8 million were recognized for the three and nine months ended September 30, 2006, respectively. The compensation cost for the nine months ended September 30, 2006 is net of a cumulative pretax adjustment of $3.9 million resulting from a change in estimating the forfeiture rate for unvested restricted share and restricted share unit awards as of January 1, 2006, as required by SFAS 123R.
As a result of adopting SFAS 123R, the Corporations income before income taxes for the three and nine months ended September 30, 2006 was $7.8 million and $23.4 million lower, respectively, than had it continued to account for stock-based compensation under APB 25. Also, the Corporations net income for the three and nine months ended September 30, 2006 was $5.1 million and $15.6 million lower, respectively, than had it continued to account for stock-based compensation under APB 25. Basic and diluted earnings per share for the three and nine month periods ended September 30, 2006 are lower than if the Corporation had continued to account for the stock-based compensation under APB 25 by $0.01 and $0.03, respectively.
The Corporation recognized stock-based compensation costs, for restricted shares and restricted share units only, of $8.7 million and $24.8 million for the three and nine months ended September 30, 2005, respectively.
The fair value of stock option awards granted on or after January 1, 2006 was determined using a Black-Scholes-Merton option-pricing formula utilizing a range of assumptions related to dividend yield, volatility, risk-free interest rate, and employee exercise behavior. Dividend yield is based on historical experience and expected future dividend actions. Expected volatility is based on a blend of historical volatility and implied volatility from traded options on the Corporations common stock. Prior to January 1, 2006, volatility was based on historical experience only. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant. The Corporation estimates forfeitures based on historical data.
7
The weighted-average fair value of the options granted for the three and nine months ended September 30, 2006 was estimated at $10.44 and $10.10 per option, respectively, on the date of grant based on the following assumptions:
September 30, 2006
Dividend yield
3.50
%
Volatility
17.58
17.84
Risk-free interest rate
5.04
Expected life years
6.0
As of September 30, 2006, the total remaining unrecognized compensation cost related to non-vested stock options, and non-vested restricted shares and time-based restricted share units, aggregated $46.0 million and $33.9 million, respectively, which will be amortized over the weighted-average service period of 1.1 years and 2.8 years, respectively. As of September 30, 2006, the total remaining unrecognized compensation cost related to non-vested, performance-based restricted share units aggregated $18.5 million, which will be amortized over the weighted-average service period of 1.8 years.
On November 10, 2005, the FASB issued FASB Staff Position No. FAS 123(R)-3, Transition Election Related to Accounting for Tax Effects of Share-Based Payment Awards. The Corporation has elected to adopt the shortcut method provided in the FASB Staff Position for determining the initial pool of excess tax benefits available to absorb tax deficiencies related to stock-based compensation subsequent to the adoption of SFAS 123R. The shortcut method includes simplified procedures to establish the beginning balance of the pool of excess tax benefits (the APIC Tax Pool) and to determine the subsequent effect on the APIC Tax Pool and Cash Flow Statements of the tax effects of employee stock-based compensation awards.
Prior to the adoption of SFAS 123R, all tax benefits from deductions resulting from the exercise of stock options and the vesting of restricted shares and restricted share units were presented as operating cash flows in the Cash Flow Statement. SFAS 123R requires the cash flow tax benefits resulting from tax deductions in excess of the compensation cost recognized (excess tax benefits) to be classified as financing cash flows. Excess tax benefits aggregating $17.9 million were classified as Other cash inflows under Financing Activities for the nine months ended September 30, 2006. As required by SFAS 123R, the prior period Cash Flow Statement was not restated.
In prior periods, the Corporation had calculated pro forma employee compensation cost for stock options on an accelerated method required by SFAS 123. The Corporation elected, for all stock option awards granted on or after January 1, 2006, to recognize compensation cost on a straight-line basis over the requisite service period for the entire award as permitted by SFAS 123R.
8
The following presents information about net income and earnings per share (EPS) as if the Corporation had applied the fair value expense recognition requirements of SFAS 123 to all stock options granted under the Equity Participation Plan.
September 30, 2005
Net income, as reported
Add: Stock-based compensation expense
included in reported net income, net of
income taxes
5.4
15.6
Less: Stock-based compensation expense
determined under the fair value requirements
of SFAS 123, net of income taxes
(12.7
(44.4
Pro forma net income
318.0
1,168.4
Earnings per share
Basic as reported
Basic pro forma
.67
2.45
Diluted as reported
Diluted pro forma
2.43
Note 3. Strategic Cost Reduction Plan
In July 2005, the Corporation authorized a multi-year plan to further improve its competitive position by accelerating investments in targeted growth opportunities and strategic cost reductions aimed at streamlining manufacturing and administrative operations, primarily in North America and Europe.
The strategic cost reductions commenced in the third quarter of 2005 and are expected to be substantially completed by December 31, 2008. Based on current estimates, the strategic cost reductions are expected to result in cumulative charges of approximately $1.0 to $1.1 billion before tax ($700 - $775 million after tax) over that three and one-half year period.
By the end of 2008, it is anticipated there will be a net workforce reduction of about 10 percent, or approximately 6,000 employees. Since the inception of the strategic cost reductions, a net workforce reduction of more than 2,600 has occurred. Approximately 20 manufacturing facilities, or 17 percent of the Corporations worldwide total, are expected to be sold or closed and an additional 4 facilities are expected to be streamlined. As of September 30, 2006, charges have been recorded related to strategic cost reduction initiatives for 23 facilities.
9
Note 3. (Continued)
In connection with the strategic cost reductions, pretax charges totaling $123.6 million were incurred in the third quarter of 2006; $91.2 million after tax. Year-to-date charges total $421.6 million; $306.5 million after tax.
The following table summarizes total pretax charges for the third quarter and year-to-date for 2006:
Noncash charges
45.0
228.4
Charges for workforce reductions
61.4
156.4
Other cash charges
14.3
32.4
Charges for special pension benefits
2.9
4.4
Total pretax charges
123.6
421.6
The following table summarizes the noncash charges totaling $45.0 million for the third quarter and $228.4 million year-to-date.
Incremental depreciation and amortization
35.1
169.5
Asset write-offs
9.4
47.1
(Gain) loss on asset dispositions
(2.9
8.4
In connection with the strategic cost reductions, pretax charges totaling $168.0 million were incurred in the third quarter of 2005; $126.4 million after tax. The following table summarizes the noncash charges totaling $140.4 million for the third quarter and year-to-date.
Three and Nine Months Ended
41.9
31.5
140.4
10
The following table summarizes the charges recorded for workforce reductions and other cash charges and reconciles such charges to accrued expenses at September 30, 2006:
Accrued expenses at December 31, 2005
28.2
Cash payments
(120.3
Currency
(.3
Accrued expenses at September 30, 2006
96.4
During the three month and nine month periods ended September 30, 2006, the Corporation also recorded charges for special pension benefits aggregating $2.9 million and $4.4 million, respectively.
Termination benefits related to workforce reductions were accrued in accordance with the requirements of SFAS No. 146, Accounting for Costs Associated with Exit or Disposal Activities (SFAS 146), SFAS No. 112, Employers Accounting for Postemployment Benefits, and SFAS No. 88, Employers Accounting for Settlements & Curtailments of Defined Benefit Pension Plans and for Termination Benefits, as appropriate. Retention bonuses related to workforce reductions were accrued in accordance with SFAS 146. The majority of the termination benefits and retention bonuses will be paid within 12 months of accrual. The termination benefits were provided under: a special-benefit arrangement for affected employees in the U.S.; standard benefit practices in the U.K.; applicable union agreements; or local statutory requirements, as appropriate. Incremental depreciation and amortization was based on changes in useful lives and estimated residual values of assets that are continuing to be used, but will be removed from service before the end of their originally assumed service period.
Costs of the initiatives have not been recorded at the business segment level, as the strategic cost reductions are Corporate decisions. These charges are included in the following income statement captions:
80.2
302.3
46.7
111.7
(3.3
7.6
(32.4
(115.1
Minority owners share of subsidiaries net income
(.2
(1.6
Total after-tax charges
91.0
304.9
11
160.5
7.5
168.0
(41.6
126.4
See Note 10 for additional information on the strategic cost reductions by business segment.
Actual pretax charges recorded for the three months ended September 30, 2006, for the strategic cost reductions relate to activities in the following geographic areas:
North
America
Europe
Total
23.5
8.1
3.5
-
.5
1.5
Charges for workforce reductions and
special pension benefits
13.4
48.0
64.3
Loss on asset disposals and other charges
5.0
4.9
11.4
Total charges
42.4
71.8
Actual pretax charges recorded for the nine months ended September 30, 2006, for the strategic cost reductions relate to activities in the following geographic areas:
101.1
46.5
21.9
24.0
21.4
1.7
38.8
113.4
8.6
160.8
23.0
16.1
40.8
186.9
200.8
33.9
12
Note 4. Inventories
The following schedule presents inventories by major class as of September 30, 2006 and December 31, 2005:
At lower of cost on the First-In, First-Out (FIFO) method or market:
Raw materials
358.6
338.9
Work in process
297.6
236.7
Finished goods
1,203.5
1,128.9
Supplies and other
238.0
232.3
2,097.7
1,936.8
Excess of FIFO cost over Last-In, First-Out (LIFO) cost
(209.4
(184.7
The Corporation uses the LIFO method of valuing inventory for financial reporting purposes for most U.S. inventories. An actual valuation of inventory under the LIFO method is made at the end of each year based on the inventory levels and costs at that time. Accordingly, interim LIFO calculations are based on managements estimates of expected year-end inventory levels and costs and are subject to the final year-end LIFO inventory valuation.
FIFO cost of total inventories on the LIFO method was $891.9 million and $857.6 million at September 30, 2006 and December 31, 2005, respectively.
Note 5. Synthetic Fuel Partnerships
The Corporation has minority interests in two synthetic fuel partnerships. The production of synthetic fuel results in pretax losses that are reported as nonoperating expense on the Corporations Consolidated Income Statement. The production of synthetic fuel results in tax credits as well as tax deductions for the nonoperating losses, which reduce the Corporations income tax expense. The effects of those losses and benefits for 2006 and 2005 are shown in the following tables:
Three Months Ended September 30
Tax credits
15.5
41.0
Tax benefit of nonoperating expense
6.2
15.1
56.1
Net synthetic fuel benefit
4.5
12.9
Per share basis diluted
.01
.03
13
Note 5. (Continued)
Nine Months Ended September 30
35.9
129.7
14.5
50.4
48.1
177.8
9.8
40.4
.02
.08
Note 6. Employee Postretirement Benefits
The table below presents the interim period disclosure required by SFAS No. 132 (revised 2003), Employers Disclosures about Pensions and Other Postretirement Benefits.
Defined
Other Postretirement
Benefit Plans
Service cost
22.1
3.7
4.0
Interest cost
74.9
72.6
11.8
Expected return on plan assets
(84.7
(80.0
Recognized net actuarial loss
25.0
22.8
1.0
(.7
.8
.3
Net periodic benefit cost
35.6
17.3
17.1
65.8
62.2
11.2
12.0
223.1
219.9
35.3
(252.5
(241.6
75.2
68.3
3.0
9.0
2.5
.9
120.6
112.5
52.0
51.1
During the first nine months of 2006 and 2005, the Corporation made cash contributions of approximately $58 million to its pension trusts outside the U.S. The Corporation currently anticipates contributing about $80 million for the full year 2006 to its pension trusts outside the U.S.
14
Note 7. Earnings Per Share
There are no adjustments required to be made to net income for purposes of computing basic and diluted EPS. The average number of common shares outstanding used in the basic EPS computations is reconciled to those used in the diluted EPS computation as follows:
Average Common Shares Outstanding
Three Months
(Millions of shares)
457.6
473.6
459.0
477.2
Dilutive effect of stock options
2.4
Dilutive effect of restricted share and share unit
awards
1.3
1.1
.7
459.8
476.8
460.9
480.8
Options outstanding during the three- and nine-month periods ended September 30, 2006 to purchase 8.6 million and 13.3 million shares of common stock, respectively, were not included in the computation of diluted EPS because the exercise prices of the options were greater than the average market price of the common shares.
Options outstanding during the three- and nine-month periods ended September 30, 2005 to purchase 9.0 million and 5.4 million shares of common stock, respectively, were not included in the computation of diluted EPS because the exercise prices of the options were greater than the average market price of the common shares.
The number of common shares outstanding as of September 30, 2006 and 2005 was 457.7 million and 469.8 million, respectively.
Note 8. Stockholders Equity
On September 14, 2006, the board of directors authorized the retirement of 90 million shares of treasury stock, which become authorized but unissued shares.
The following tables present the activity of the Corporations stock-based compensation plans for the nine-month period ended September 30, 2006:
Weighted-
Average
Aggregate
Remaining
Intrinsic
Shares
Exercise
Contractual
Value
Stock Options
(000s)
Price
Term
($000)
Outstanding at January 1, 2006
32,622
$56.99
Granted
4,779
58.75
Exercised
(4,493
48.94
Forfeited or expired
(664
62.93
Outstanding at September 30, 2006
32,244
58.23
5.6
$230,052
Exercisable at September 30, 2006
23,308
57.43
$184,843
15
Note 8. (Continued)
The total intrinsic value of stock options exercised during the three- and nine-month periods ended September 30, 2006 was $28.4 million and $56.8 million, respectively.
Time-Based
Performance-Based
Restricted Shares
Restricted Share Units
Grant-Date
Other Stock-Based Awards
Fair Value
Nonvested at January 1, 2006
624
51.82
873
58.95
467
62.82
290
58.83
253
58.74
Vested
(5
56.20
(26
62.18
Forfeited
(32
48.18
(34
59.30
(19
62.77
Nonvested at September 30,
587
52.01
1,103
57.81
701
57.50
The total fair value of shares and share units that became vested during the three- and nine-month periods ended September 30, 2006 was $0.7 million and $1.9 million, respectively.
Note 9. Comprehensive Income
Comprehensive income includes all changes in stockholders equity during the periods except those resulting from investments by and distributions to stockholders.
The following schedule presents the components of comprehensive income:
Unrealized currency translation adjustments, net of tax
222.5
(320.0
Deferred (losses) gains on cash flow hedges, net of tax
(11.0
27.4
Unrealized holding gains on available-for-sale securities
.1
Comprehensive income
1,228.5
904.6
Net unrealized currency gains or losses resulting from the translation of assets and liabilities of
non-U.S. subsidiaries, except those in highly inflationary economies, are accumulated in a separate section of stockholders equity. For these operations, changes in exchange rates generally do not affect cash flows; therefore, unrealized translation adjustments are recorded in stockholders equity rather than income. Upon sale or substantially complete liquidation of any of these subsidiaries, the applicable unrealized translation adjustment would be removed from stockholders equity and reported as part of the gain or loss on the sale or liquidation.
Also included are the effects of foreign exchange rate changes on intercompany balances of a long-term investment nature and transactions designated as hedges of net foreign investments.
16
Note 9. (Continued)
The net unrealized currency translation adjustments for the nine months ended September 30, 2006 is primarily due to a weakening of the U.S. dollar versus the euro, the South Korean won and the Brazilian real.
Note 10. Description of Business Segments
The Corporation is organized into operating segments based on product groupings. These operating segments have been aggregated into four reportable global business segments: Personal Care; Consumer Tissue; K-C Professional & Other; and Health Care. The reportable segments were determined in accordance with how the Corporations executive managers develop and execute the Corporations global strategies to drive growth and profitability of the Corporations worldwide Personal Care, Consumer Tissue, K-C Professional & Other and Health Care operations. These strategies include global plans for branding and product positioning, technology, research and development programs, cost reductions including supply chain management, and capacity and capital investments for each of these businesses. Segment management is evaluated on several factors, including operating profit. Segment operating profit excludes other income and (expense), net; income and expense not associated with the business segments; and the costs of corporate decisions related to the strategic cost reductions described in Note 3. Corporate & Other includes the costs of the strategic cost reductions.
The principal sources of revenue in each global business segment are described below.
The Personal Care segment manufactures and markets disposable diapers, training and youth pants and swimpants; baby wipes; feminine and incontinence care products; and related products. Products in this segment are primarily for household use and are sold under a variety of brand names, including Huggies, Pull-Ups, Little Swimmers, GoodNites, Kotex, Lightdays, Depend, Poise and other brand names.
The Consumer Tissue segment manufactures and markets facial and bathroom tissue, paper towels, napkins and related products for household use. Products in this segment are sold under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Hakle, Page and other brand names.
The K-C Professional & Other segment manufactures and markets facial and bathroom tissue, paper towels, napkins, wipers and other products to the away-from-home marketplace. Products in this segment are sold under the Kimberly-Clark, Kleenex, Scott, Kimwipes, WypAll, Surpass and other brand names.
The Health Care segment manufactures and markets health care products such as surgical gowns, drapes, infection control products, sterilization wrap, disposable face masks and exam gloves, respiratory products and other disposable medical products. Products in this segment are sold under the Kimberly-Clark, Safeskin, Tecnol, Ballard and other brand names.
17
Note 10. (Continued)
The following schedules present information concerning consolidated operations by business segment.
NET SALES:
Personal Care
1,714.7
1,606.7
5,054.8
4,741.2
Consumer Tissue
1,475.2
1,431.0
4,406.8
4,295.6
K-C Professional & Other
694.7
654.7
2,007.9
1,927.7
Health Care
331.0
306.7
992.9
921.8
Corporate & Other
6.7
22.3
Intersegment sales
(12.0
(5.0
(46.2
(14.9
Consolidated
OPERATING PROFIT (reconciled to income
before income taxes):
331.6
316.7
960.2
943.5
180.2
189.8
566.8
596.4
119.1
114.2
321.1
319.3
59.5
54.8
185.5
174.8
Other income and (expense), net
(12.3
(21.7
(25.7
(164.1
(198.6
(521.0
(269.9
Total Operating Profit
Income Before Income Taxes
18
Note:
Other income and (expense), net and Corporate & Other include the following amounts of pretax charges for the strategic cost reductions.
3.3
(7.6
(126.9
(168.0
(414.0
The following table presents the pretax charges for the strategic cost reductions related to activities in the Corporations business segments:
45.2
117.0
217.1
17.8
142.7
12.2
10.7
22.9
14.2
22.5
38.9
Total pretax charges that are expected to be incurred for the strategic cost reduction plan by business segment are: Personal Care - $530 to $540 million; Consumer Tissue - $260 to $270 million;
K-C Professional & Other - $80 to $90 million; and Health Care - $140 to $150 million.
19
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations.
Introduction
This managements discussion and analysis of financial condition and results of operations is intended to provide investors with an understanding of the Corporations recent performance, its financial condition and its prospects. The following will be discussed and analyzed:
Overview of Third Quarter 2006 Results
Business Segments
Results of Operations and Related Information
Liquidity and Capital Resources
Environmental Matters
Business Outlook
Net sales increased 5.2 percent
Operating profit and net income increased by 13.3 percent and 12.0 percent, respectively
Cash provided by operations was $647.8 million
As a result of organizational changes that were effective January 1, 2006, the Corporation is reporting four business segments. The two new business segments, K-C Professional & Other and Health Care, had previously been combined into the Business-to-Business segment. The Personal Care and Consumer Tissue business segments were not affected by the organizational changes and will continue to be reported on their historical basis.
The K-C Professional & Other segment manufactures and markets facial and bathroom tissue, paper towels, napkins, wipers and other products principally to the away-from-home marketplace. The Health Care segment manufactures and markets health care products such as surgical gowns, drapes, infection control products, sterilization wrap, disposable face masks and exam gloves, respiratory products and other disposable medical products.
This section presents a discussion and analysis of the Corporations third quarter and first nine months of 2006 net sales, operating profit and other information relevant to an understanding of the results of operations.
20
Third Quarter of 2006 Compared With Third Quarter of 2005
Analysis of Net Sales
By Business Segment
Commentary:
Percent Change in Net Sales Versus Prior Year
Changes Due To
Volume
Net
Mix/
Change
Growth
1
(1
(3
Consolidated net sales were 5.2 percent higher than in 2005. Net sales benefited from a combination of improved sales volumes, higher net selling prices and favorable product mix, each approximately 1 percent better than the prior year. Changes in foreign currency exchange rates also added nearly 2 percent to net sales. In addition to the continued strong performance in developing and emerging markets, highlights for the quarter included volume growth for the Corporations child care, incontinence care and wipes brands in North America and for health care globally. Overall volume growth was tempered by declines in consumer tissue sales volumes in North America and Europe.
Personal care net sales advanced 6.7 percent in the third quarter, driven primarily by sales volume growth of approximately 5 percent, along with currency benefits of 2 percent. Favorable product mix of 1 percent versus the prior year was offset by a decline in net selling prices.
Personal care net sales in North America increased about 2 percent compared with the third quarter of 2005. Higher sales volumes accounted for the entire increase, led by upper single-digit volume gains for the Corporations market-leading Huggies baby wipes, Pull-Ups training pants, and Depend and Poise incontinence care products. Infant care volumes were even with
21
a strong year-ago base period, when volumes were up 7 percent. In feminine care, although Kotex brand sales volumes were down from last year, third quarter shipments were similar to first and second quarter levels. Favorable currency effects added 1 percent to net sales, while net selling prices decreased about 1 percent to match competitive activity and support product initiatives. In Europe, personal care net sales increased more than 4 percent, with stronger currencies in the region boosting sales comparisons. Overall sales volumes and net selling prices were essentially the same as the prior year. Diaper volumes rose 2 percent, with sales volumes of Huggies diapers about 6 percent ahead of last year in the Corporations four core European markets the U.K., France, Italy and Spain. In developing and emerging markets, personal care net sales improved 15 percent, paced by double-digit increases in North Asia, Latin America, and Middle East/Africa/Eastern Europe. Higher sales volumes, better product mix and currency benefits all contributed to the increase.
Consumer tissue net sales increased 3.1 percent versus the third quarter of 2005. Net selling prices increased approximately 4 percent, as price increases have been implemented in every region of the world, and currency effects contributed an additional 2 percent. These improvements, however, were partially offset by a 3 percent decrease in sales volumes overall, driven primarily by declines in North America and Europe.
In North America, third quarter net sales of consumer tissue products rose approximately 1 percent, as net selling prices were about 4 percent higher and product mix improved 1 percent, while sales volumes declined by 4 percent. Pricing benefited from increases implemented earlier in the year for Kleenex facial tissue, Cottonelle and Scott bathroom tissue and Viva and Scott paper towels. The reduction in sales volumes was primarily attributable to lower sales of rolled products compared with double-digit growth overall in last years quarter. Meanwhile, third quarter sales volumes of Kleenex facial tissue began to rebound from second quarter levels and were slightly higher than in 2005. In Europe, consumer tissue sales increased 4 percent. Net selling prices increased about 4 percent, as the Corporation has implemented price increases in a number of European markets so far this year. Product mix also improved by 2 percent and currency effects added 5 percent to sales. Sales volumes, however, went down approximately 7 percent, which the Corporation believes is a short-term consequence of its disciplined approach to implementing the price increases. Plans are in place to improve sales over the balance of the year in both North America and Europe. Consumer tissue net sales in developing and emerging markets rose 9 percent, with growth in all regions, driven primarily by higher net selling prices, increased sales volumes and favorable currency exchange rates.
Net sales of K-C Professional & Other products were 6.1 percent above the year-ago quarter. Net selling prices increased about 3 percent and sales volumes rose approximately 1 percent, while currency benefits added 2 percent to sales. K-C Professionals key strategies to improve revenue realization and shift volume to more profitable market segments with distinctive, differentiated products such as Kleenex and Scottfold hand towels, WypAll X80 towels, Kimtech wipers and offerings for the Do-It-Yourself channel continue to deliver overall top-line growth.
Net sales of health care products climbed 7.9 percent in the quarter, highlighted by continued strong volume growth of 7 percent. The business is experiencing broad-based growth in face masks, sterilization wrap and exam gloves, including the Corporations new Sterling Nitrile brand. Favorable product mix also benefited third quarter sales by 1 percent.
22
By Geography
North America
2,429.2
2,372.6
Outside North America
1,938.8
1,761.5
Intergeographic sales
(157.6
(133.3
Net sales in North America increased 2.4 percent primarily due to the higher sales volumes for personal care products and the higher net selling prices for consumer tissue and K-C Professional products, partially offset by the lower consumer tissue sales volumes.
Net sales outside North America increased 10.1 percent primarily because of the previously mentioned strength in the developing and emerging markets, and favorable currency effects principally in Europe.
Analysis of Operating Profit
23
Percentage Change in Operating Profit Versus Prior Year
Change Due To
Raw
Energy and
Materials
Distribution
Cost
Expense
Other (a)
(16
(11
(b)
(7
(8
29
(15
(17
K-C Professional
& Other
(10
(a)
Includes cost savings achieved, net of higher marketing and general expenses.
Charges for the strategic cost reductions were about $45 million lower in 2006 than in 2005.
Consolidated operating profit for the third quarter of 2006 rose $61.8 million or 13.3 percent from the prior year. This increase was primarily due to the higher net selling prices of about $50 million, cost savings of more than $80 million and lower charges for strategic cost reductions of nearly $45 million, partially offset by cost inflation of about $105 million. Cost savings were achieved through the Corporations ongoing cost management program FORCE (Focused On Reducing Costs Everywhere) with cost reductions of more than $45 million, along with benefits from the strategic cost reduction plan of approximately $35 million. Charges for strategic cost reductions, discussed later in this MD&A and in Note 3 to the Consolidated Financial Statements, are not included in the business segments. The inflationary cost increases included about $35 million in higher fiber costs, about $35 million for raw materials other than fiber, driven by increases in the cost of polymer resins, superabsorbents and other oil-based materials, $20 million in energy costs and approximately $15 million in distribution costs. As discussed in Note 2 to the Consolidated Financial Statements, effective January 1, 2006, the Corporation adopted Statement of Financial Accounting Standards No. 123R, Share-Based Payment (SFAS 123R). Stock option expense under the provisions of SFAS 123R reduced third quarter 2006 operating profit by about $8 million.
Personal care segment operating profit increased 4.7 percent as the benefits of higher sales volumes and cost savings more than offset lower net selling prices and raw material cost inflation. In North America, cost savings, higher sales volumes and lower marketing expenses more than offset lower net selling prices and cost inflation. Operating profit in Europe improved primarily due to cost savings. In the developing and emerging markets, higher net sales more than offset increased marketing expenses.
Consumer tissue segment operating profit decreased 5.1 percent because cost inflation and lower sales volumes more than offset the benefits of higher net selling prices and cost savings. In North America, higher pulp and distribution costs more than offset increased net selling prices and cost savings. Operating profit in Europe was even with last year as higher net selling prices were offset by increased manufacturing costs. In the developing and emerging markets, operating profit was slightly below last years results because higher distribution and marketing costs more than offset increased net selling prices.
24
Operating profit for K-C Professional & Other products increased 4.3 percent primarily due to the higher net selling prices and cost savings, tempered by higher pulp costs and increased energy and distribution expenses.
Health care segment operating profit advanced 8.6 percent because of the increased sales volumes and cost savings, partially offset by materials cost inflation and higher distribution expenses.
Other income and (expense), net includes lower currency losses in 2006 compared to 2005.
496.1
517.7
194.3
157.8
Operating profit in North America decreased 4.2 percent primarily due to lower earnings in the consumer tissue business.
Operating profit outside North America increased 23.1 percent primarily due to improved results in Europe and Latin America in the personal care business.
Strategic Cost Reductions
During the third quarter of 2006, the Corporation made further progress implementing the strategic cost reduction plan that will support the targeted growth investments announced in July 2005. As previously disclosed, the Corporation plans to reduce costs by streamlining manufacturing and administrative operations primarily in North America and Europe, creating an even more competitive platform for growth and margin improvement.
Pretax charges totaling $123.6 million ($91 million after tax) related to these cost reduction initiatives were recorded in the third quarter of 2006. A majority of the pretax charges were for current or future cash outlays, primarily for costs related to workforce reductions. Major components of the charges
25
were for consolidation of consumer tissue operations in Europe and North American infant and child care operations, as well as for streamlining administrative operations in North America and Europe.
To date, employees have been notified about workforce reductions and other actions at 19 of the approximately 24 facilities slated for sale, closure or streamlining as part of the cost reduction initiatives, and pretax charges of $650 million (about $472 million after tax) have been recorded. The Corporation currently expects to incur cumulative pretax charges of $1.0 to $1.1 billion ($700 to $775 million after tax) through the end of 2008 that will yield annual pretax savings of at least $350 million in 2009. See Note 3 to the Consolidated Financial Statements for additional detail on the costs recorded in the third quarter.
Savings of approximately $35 million were realized in the third quarter of 2006, bringing the
year-to-date total to nearly $75 million. Based upon results to date and plans for the balance of the year, the Corporation expects to achieve at least $100 million of savings in 2006. Pretax charges for the full year are expected to total approximately $500 million.
The strategic cost reductions are corporate decisions and are not included in the business segments operating profit performance. See Note 10 to the Consolidated Financial Statements for the 2006 costs of the strategic cost reductions related to the activities in the Corporations business segments. Third quarter 2006 charges have been recorded in Cost of Products Sold ($80.2 million) and Marketing, Research and General Expenses ($46.7 million); and a gain of $3.3 million on the disposal of a mill has been included in Other income and (expense), net.
Additional Income Statement Commentary
Nonoperating expense of $17.2 million for the third quarter of 2006 is the Corporations pretax loss associated with its ownership interest in the synthetic fuel partnerships described in Note 5 to the Consolidated Financial Statements.
Interest expense increased 17.7 percent primarily due to higher average interest rates.
The Corporations effective tax rate in the third quarter was 24.9 percent in 2006 and 17.4 percent in 2005. The increase was due primarily to a lower level of income tax benefits from the Corporations ownership interests in the synthetic fuel partnerships. Net of related nonoperating expense, the tax benefits contributed about $5 million to net income in 2006 versus $13 million in 2005.
The Corporations share of net income of equity affiliates rose 29.7 percent primarily due to higher earnings at Kimberly-Clark de Mexico, S.A. de C.V. (KCM). KCMs results were driven by higher net selling prices and higher sales volumes, as well as lower currency transaction losses than in 2005.
As a result of the Corporations ongoing share repurchase program, the average number of common shares outstanding declined, benefiting third quarter 2006 results by $.03 per share compared with last year.
26
First Nine Months of 2006 Compared With First Nine Months of 2005
(2
Consolidated net sales for the first nine months of 2006 increased 4.6 percent.
Personal care net sales increased 6.6 percent principally due to higher sales volumes in North America and the developing and emerging markets. Favorable currency effects, primarily in North America, Korea and Brazil were offset by overall lower net selling prices.
Consumer tissue net sales increased 2.6 percent because of higher net selling prices in each region, principally in North America, partially offset by lower sales volumes, primarily in North America and Europe. Unfavorable currency effects in Europe were essentially offset by favorable currency in Korea and Brazil.
Net sales of K-C Professional & Other products increased 4.2 percent due to higher net selling prices and improved product mix.
Health care net sales advanced 7.7 percent on the strength of higher sales volumes and favorable product mix.
27
7,224.9
6,990.6
5,649.5
5,305.2
(434.7
(402.1
Net sales in North America increased 3.4 percent primarily due to the higher sales volumes for personal care and the higher net selling prices for consumer tissue and K-C Professional & Other products, partially offset by lower net selling prices for personal care and lower consumer tissue sales volumes.
Net sales outside North America increased 6.5 percent principally because of the continued strength in the developing and emerging markets.
28
(14
(9
Includes higher marketing and general expenses, net of cost savings achieved.
Charges for strategic cost reductions were $253.6 million higher in 2006 than in 2005.
Consolidated operating profit declined $247.5 million or 14.2 percent from the prior year. This decrease was primarily due to $253 6 million in additional charges for the strategic cost reductions in 2006 compared with 2005. Total charges for the strategic cost reductions were $421.6 million in 2006 versus $168.0 million in 2005. Through the first nine months of 2006, higher sales volumes and increased net selling prices, along with cost savings of about $175 million, offset cost inflation of approximately $295 million and higher marketing and general expenses. Stock option expense reduced operating profit by about $27 million for the first nine months of 2006.
Personal care segment operating profit increased 1.8 percent because the benefits of higher sales volumes and cost savings more than offset cost inflation, lower net selling prices and higher marketing and general expenses.
Consumer tissue segment operating profit decreased 5.0 percent as increased net selling prices and cost savings were more than offset by cost inflation, higher marketing and general expenses and lower sales volumes.
Operating profit for K-C Professional & Other products increased .6 percent as higher net selling prices, increased sales volumes, improved product mix and cost savings were nearly offset by cost inflation and higher marketing and general expenses.
Health care segment operating profit advanced 6.1 percent due to the benefits of higher sales volumes, a favorable product mix and cost savings, tempered by cost inflation.
Other income and (expense), net for 2006 includes a loss on the first quarter sale of one of the properties that was disposed of as part of the strategic cost reductions. The effect of this loss was more than offset by lower foreign currency transaction losses in 2006 compared with 2005. In addition, an insurance settlement gain is included in 2005.
1,478.7
1,565.1
554.9
468.9
Operating profit in North America decreased 5.5 percent primarily because of lower earnings in the consumer tissue and personal care businesses tempered by higher earnings in K-C Professional.
Operating profit outside North America increased 18.3 percent primarily due to higher earnings in Europe and Latin America in the personal care business and in the health care business.
Nonoperating expense of $40.6 million for the first nine months of 2006 is the Corporations pretax loss associated with its ownership interest in the synthetic fuel partnerships described in Note 5 to the Consolidated Financial Statements.
Under the Internal Revenue Code, the ability to use tax credits from the production of synthetic fuel is phased-out when the average annual domestic price of oil exceeds certain statutory amounts. The average annual domestic price for 2006 is estimated to result in a partial phase-out of the tax credits. These estimates will be updated as the year progresses, and may result in an adjustment in the fourth quarter to the credits recognized in the first nine months of 2006.
Interest expense increased 20.0 percent primarily due to higher average interest rates.
The Corporations effective tax rate was 26.4 percent in 2006 compared with 21.8 percent in 2005. A lower level of synthetic fuel tax benefits and related nonoperating expense than in the prior year were the main reasons the 2006 effective tax rate increased from 2005.
The Corporations share of net income of equity affiliates rose 25.5 percent primarily due to higher earnings at KCM. KCMs performance was driven by continued strong results in its consumer business, as well as lower currency transaction losses than in 2005.
30
Minority owners share of subsidiaries net income increased 7.5 percent, primarily due to higher earnings at certain of the Corporations subsidiaries in Latin America, tempered by lower earnings of a subsidiary in the Middle East.
As a result of the Corporations ongoing share repurchase program, the average number of common shares outstanding declined, benefiting 2006 results by $.09 per share compared with last year.
Cash provided by operations for the first nine months of 2006 increased by $130.8 million compared with 2005 primarily due to a decreased investment in working capital.
Capital spending for the first nine months of 2006 was $639.0 million. The Corporation continues to target full year capital spending between $900 million and $1 billion.
During the first nine months of 2006, the Corporation repurchased about 7.7 million shares of its common stock at a cost of approximately $464 million, including nearly 2.9 million shares repurchased during the third quarter at a cost of about $180 million. The Corporation continues to target total share repurchases of $750 million for the year.
At September 30, 2006, total debt and preferred securities was $4.4 billion compared to $4.6 billion at December 31, 2005.
On October 27, 2006, KCM announced the sale of its pulp and paper businesses. These businesses had accounted for approximately 10 percent of KCMs operating profit in 2005. As a result of the sale of these businesses, KCMs board of directors is expected to declare a special dividend, payable in the fourth quarter of 2006.
Management believes that the Corporations ability to generate cash from operations and its capacity to issue short-term and long-term debt are adequate to fund working capital, capital spending, payment of dividends, repurchases of common stock and other needs in the foreseeable future.
See Note 1 to the Consolidated Financial Statements for information on recently issued accounting standards.
The Corporation has been named a potentially responsible party under the provisions of the federal Comprehensive Environmental Response, Compensation and Liability Act, or analogous state statutes, at a number of waste disposal sites, none of which, individually or in the aggregate, in managements opinion, is likely to have a material adverse effect on the Corporations business, financial condition, results of operations, or liquidity.
31
For the fourth quarter, the Corporation expects solid top-line growth, driven by continued strength in developing and emerging markets, along with higher net selling prices, increased sales volumes and product mix improvements. At current exchange rates, foreign currency is also expected to contribute positively. In addition, the Corporation expects cost reductions will continue to ramp up and KCM will sustain its excellent performance. However, it is anticipated that inflation will continue to significantly impact the Corporations costs. As oil costs have decreased, there has been some benefit in distribution costs; however, there has not yet been any meaningful reduction in the cost of polymer resins or packaging. Meanwhile, pulp costs have moved somewhat higher.
Information Concerning Forward-Looking Statements
Certain matters discussed in this report concerning, among other things, the business outlook, including new product introductions, cost savings, anticipated financial and operating results, strategies, contingencies and contemplated transactions of the Corporation, constitute forward-looking statements and are based upon managements expectations and beliefs concerning future events impacting the Corporation. There can be no assurance that these events will occur or that the Corporations results will be as estimated.
The assumptions used as a basis for the forward-looking statements include many estimates that, among other things, depend on the achievement of future cost savings and projected volume increases. In addition, many factors outside the control of the Corporation, including the prices of the Corporations raw materials, potential competitive pressures on selling prices or advertising and promotion expenses for the Corporations products, and fluctuations in foreign currency exchange rates, as well as general economic conditions in the markets in which the Corporation does business, could impact the realization of such estimates.
For a description of these and other factors that could cause the Corporations future results to differ materially from those expressed in any such forward-looking statements, see Part I, Item 1A of the Corporations Annual Report on Form 10-K for the year ended December 31, 2005 entitled Risk Factors.
Item 4. Controls and Procedures.
As of September 30, 2006, an evaluation was performed under the supervision and with the participation of the Corporations management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Corporations disclosure controls and procedures. Based on that evaluation, the Corporations management, including the Chief Executive Officer and Chief Financial Officer, concluded that the Corporations disclosure controls and procedures were effective as of September 30, 2006. There have been no significant changes during the quarter covered by this report in the Corporations internal control over financial reporting or in other factors that could significantly affect internal control over financial reporting.
32
PART II OTHER INFORMATION
Item 2. Stock Repurchases.
The Corporation regularly repurchases shares of Kimberly-Clark common stock pursuant to publicly announced share repurchase programs. All share repurchases by the Corporation were made through brokers in the open market. During 2006, the Corporation anticipates purchasing $750 million of its common stock. The following table contains information for shares repurchased during the third quarter of 2006. None of the shares in this table were repurchased directly from any officer or director of the Corporation.
Cumulative
Number of
Shares That
Period
Average Cost
Shares Purchased
May Be
(2006)
Purchased (1)
Per Share
Pursuant To The Plan
Repurchased
July 1 to 31
943,000
60.48
10,569,000
39,431,000
August 1 to 31
1,068,000
61.70
11,637,000
38,363,000
Sept. 1 to 30
881,000
64.80
12,518,000
37,482,000
2,892,000
(1)
Share repurchases were made pursuant to a share repurchase program authorized by the Corporations board of directors on September 15, 2005 which allowed for the repurchase of 50 million shares in an amount not to exceed $5.0 billion.
In addition, during July, August and September, 1,673 shares at a cost of $102,388; 4,248 shares at a cost of $265,741; and 590 shares at a cost of $37,925, respectively, were purchased from current or former employees in connection with the exercise of employee stock options and other awards.
Item 6. Exhibits.
Exhibits
(3)a
Restated Certificate of Incorporation, dated June 12, 1997 and Certificate Eliminating Series A Junior Participating Preferred Stock, incorporated by reference to Exhibit No. (3)a of the Corporations Annual Report on Form 10-K for the year ended December 31, 2004.
(3)b
By-Laws, as amended September 14, 2006, incorporated by reference to Exhibit No. (3)b of the Corporations Current Report on Form 8-K dated September 18, 2006.
(4)
Copies of instruments defining the rights of holders of long-term debt will be furnished to the Securities and Exchange Commission on request.
(31)a
Certification of Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended (the Exchange Act), filed herewith.
(31)b
Certification of Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act, filed herewith.
33
(32)a
Certification of Chief Executive Officer required by Rule 13a-14(b) or Rule 15d-14(b) of the Exchange Act and Section 1350 of Chapter 63 of Title 18 of the United States Code, furnished herewith.
(32)b
Certification of Chief Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) of the Exchange Act and Section 1350 of Chapter 63 of Title 18 of the United States Code, furnished herewith.
34
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
(Registrant)
By:
/s/ Mark A. Buthman
Mark A. Buthman
Senior Vice President and
Chief Financial Officer
(principal financial officer)
/s/ Randy J. Vest
Randy J. Vest
Vice President and Controller
(principal accounting officer)
November 7, 2006
35
EXHIBIT INDEX
Exhibit No.
Description